Carol T. Wismer
Abbott Fund(US)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Adenosine and Purinergic Signaling, Pharmacological Receptor Mechanisms and Effects, Quinazolinone synthesis and applications, Synthesis and Reactivity of Heterocycles
Most-Cited Works
- → A-317491, a novel potent and selective non-nucleotide antagonist of P2X 3 and P2X 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat(2002)459 cited
- → A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats(2005)254 cited
- → P2X7-related modulation of pathological nociception in rats(2007)220 cited
- → Effects of A‐317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration(2003)177 cited
- → Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties(2005)163 cited
- → Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP‐ATP and enhancement by the P2X3 allosteric modulator, cibacron blue(2001)108 cited
- → ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat(2000)104 cited
- → Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities(2004)101 cited
- → Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity(2006)100 cited
- → Design, Synthesis, and Structure−Activity Relationship of 6-Alkynylpyrimidines as Potent Adenosine Kinase Inhibitors(2002)58 cited